StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3042% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson TRACLEER [reported separately through FY2019Q4] by Quarter

TRACLEER (bosentan) [reported separately through FY2019Q4] — International operational growth YoY (%) (%)

Johnson & Johnson TRACLEER [reported separately through FY2019Q4]: -10.9% in Q2 2019. No newer figure appears in the documents we track.

Latest, Q2 2019
-10.9%
Period ended Jun 30, 2019
Change on a year earlier
–
History
4 quarters
Since Q3 2018
Sources
4
Documents cited below

Where the Q2 2019 figure comes from

“|| Intl | 62 | 72 | (14.5 | ) | (10.9 | ) | (3.6 | )”

Source: Form 8-K (a2019q2exhibit9915.htm, filed 2019-07-16) ↗

Reported in Form 8-K EX-99.2 Segment Sales Schedule.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTRACLEER (bosentan) [reported separately through FY2019Q4] — International operational growth YoY (%) (%)Year on yearSource
Q2 2019Jun 30, 2019-10.9%–Form 8-K (a2019q2exhibit9915.htm, filed 2019-07-16) ↗
Q1 2019Mar 31, 2019-18.3%–Form 8-K (a2019q1exhibit9915.htm, filed 2019-04-16) ↗
Q4 2018Dec 30, 2018-27.2%–Form 8-K (a2018q4exhibit9915.htm, filed 2019-01-22) ↗
Q3 2018Sep 30, 2018-43.6%–Form 8-K (a8k2018q3exhibit9915.htm, filed 2018-10-16) ↗

Cite this data

StockData. (2026). Johnson & Johnson TRACLEER [reported separately through FY2019Q4] (%), quarterly Q3 2018–Q2 2019 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/drug-tracleer-intl-ops-yoy

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.